High prevalence of PROP1 defects in Lithuania: Phenotypic findings in an ethnically homogenous cohort of patients with multiple pituitary hormone deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 1, 2014, Pages 299-306

  Navardauskaite, Ruta ^a   Dusatkova, Petra ^b   Obermannova, Barbora ^b   Pfaeffle, Roland W ^c   Blum, Werner F ^c   Adukauskiene, Dalia ^a   Smetanina, Natalija ^a   Cinek, Ondrej ^b   Verkauskiene, Rasa ^a   Lebl, Jan ^b  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOTROPIN DEFICIENCY; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC VARIABILITY; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HETEROZYGOSITY; HOMOZYGOSITY; HORMONE DEFICIENCY; HUMAN; LITHUANIA; LUTEINIZING HORMONE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE PITUITARY HORMONE DEFICIENCY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; ORGAN SIZE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROP1 GENE; SCHOOL CHILD; SEX DIFFERENCE; SEXUAL MATURATION; THYROID STIMULATING HORMONE DEFICIENCY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; HOMEODOMAIN PROTEINS; HUMANS; HYPOPITUITARISM; INFANT; LITHUANIA; MALE; PHENOTYPE; PITUITARY GLAND; PITUITARY HORMONES; PREVALENCE; YOUNG ADULT;

EID: 84892171122     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3090     Document Type: Article

References (41)

1. Cogan JD, Wu W, Phillips JA 3rd, et al. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab. 1998;83:3346-3349.
2. Rodriguez R, Andersen B. Cellular determination in the anterior pituitary gland: PIT-1 and PROP-1 mutations as causes of human combined pituitary hormone deficiency. Minerva Endocrinol. 2003; 28:123-133.
3. de Graaff LC, Argente J, Veenma DC, et al. PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency. Horm Res Paediatr. 2010;73:363-371.
4. Böttner A, Keller E, Kratzsch J, et al. PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab. 2004;89:5256-5265.
5. Duquesnoy P, Roy A, Dastot F, et al. Human Prop-1: cloning, mapping, genomic structure. Mutations in familial combined pituitary hormone deficiency. FEBS Lett. 1998;437:216-220.
6. Savage JJ, Yaden BC, Kiratipranon P, Rhodes SJ. Transcriptional control during mammalian anterior pituitary development. Gene. 2003;319:1-19.
7. Mendonca BB, Osorio MG, Latronico AC, Estefan V, Lo LS, Arnhold IJ. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the PROP1 gene. J Clin Endocrinol Metab. 1999;84:942-945.
8. Wu W, Cogan JD, Pfäffle RW, et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet. 1998; 18:147-149.
9. Fofanova O, Takamura N, Kinoshita E, et al. Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab. 1998;83:2601-2604.
10. Halász Z, Toke J, Patócs A, et al. High prevalence of PROP1 gene mutations in Hungarian patients with childhood-onset combined anterior pituitary hormone deficiency. Endocrine. 2006;30:255-260.
11. Halász Z. [Genetic background of inherited multiple pituitary hormone deficiency. Mutations of PROP1 gene in Hungary]. Orv Hetil. 2011;152:221-232.
12. Obermannova B, Pfaeffle R, Zygmunt-Gorska A, et al. Mutations and pituitary morphology in a series of 82 patients with PROP1 gene defects. Horm Res Paediatr. 2011;76:348-354.
13. Blum WF, Shavrikova EP, Sampson C, et al. Screening of a large cohort of pediatric patients with GH deficiency for mutations in genes involved in the regulation of pituitary development and GH secretion. Abstract. Horm Res Paediatr. 2010;74(S3):27.
14. Zygmunt-Gorska A, Starzyk J, Sucharski P, Herman-Sucharska I, Adamek D, Pietrzyk JJ. Radiological findings in patients with combined pituitary hormone deficiency due to PROP-1 gene mutation-.[Abstract]. Horm Res. 2007;68(S1):39.
15. Lemos MC, Gomes L, Bastos M, et al. PROP1 gene analysis in Portuguese patients with combined pituitary hormone deficiency. Clin Endocrinol. 2006;65:479-485.
16. Lebl J, Vosáhlo J, Pfaeffle RW, et al. Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects. Eur J Endocrinol. 2005;153:389-396.
17. Brook CGD, Clayton PE, Brown RS. Brook's Clinical Pediatric Endocrinology, 6th ed. Singapore, Hong Kong: John Wiley, Sons; 2009;76.
18. Dattani MT, Robinson IC. The molecular basis for developmental disorders of the pituitary gland in man. Clin Genet. 2000;57:337-346.
19. Agarwal G, Bhatia V, Cook S, Thomas PQ. Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J Clin Endocrinol Metab. 2000;85:4556-4561.
20. Dattani MT. GH deficiency might be associated with normal height in PROP1 deficiency. Clin Endocrinol. 2002;57:157-158.
21. Cushman LJ, Showalter AD, Rhodes SJ. Genetic defects in the development and function of the anterior pituitary gland. Ann Med. 2002;34:179-191.
22. Mody S, Brown MR, Parks JS. The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract Res Clin Endocrinol Metab. 2002;16:421-431.
23. Lawrence C, Fryer JG, Karlberg P, Niklasson A, Ericson A. Modelling of reference values for size at birth. Acta Paediatr. 1989;78:55-69.
24. Kobzova J, Vignerova J, Blaha P, Krejcovsky L, Riedlova J. The 6th nationwide anthropological survey of children and adolescents in the Czech Republic in 2001. Cent Eur J Publ Health. 2004;12:126-130.
25. Di Chiro GD, Nelson KB. The volume of the sella turcica. Am J Roentgenol Radium Ther Nucl Med. 1962;87:989-1008.
26. Takano K, Utsunomiya H, Ono H, Ohfu M, Okazaki M. Normal development of the pituitary gland: assessment with three-dimensional MR volumetry. AJNR Am J Neuroradiol. 1999;20:312-315.
27. Argyropoulou M, Perignon F, Brunelle F, Brauner R, Rappaport R. Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children. Pediatr Radiol. 1991;21:247-249.
28. Tsunoda A, Okuda O, Sato K. MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium. AJNR Am J Neuroradiol. 1997; 18:551-554.
29. Ertekin T, Acer N, Turgut AT, Aycan K, Ozçelik O, Turgut M. Comparison of three methods for the estimation of the pituitary gland volume using magnetic resonance imaging: a stereological study. Pituitary. 2011;14:31-38.
30. Tkacenko N, Lasiene D, Jakstiene S, Basevicius A, Verkauskiene R. [Evaluation of pituitary imaging in patients with prop-1 gene mudoi: tation]. Medicina (Kaunas). 2009;45:693-698. [Article in Lithuanian.]
31. Kandemir N, Vuralli D, Taskiran E, et al. Frequency of mutations in PROP-1 gene in Turkish children with combined pituitary hormone deficiency. Turkish J Pediatr. 2012;54:570-575.
32. Vieira TC, Boldarine VT, Abucham J. Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency. Arq Bras Endocrinol Metabol. 2007; 51:1097-1103.
33. Zimmermann A, Schenk JP, Grigorescu Sido P, et al. MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency-correlation with severity of hypopituitarism. J Pediatr Endocrinol Metab. 2007;20:587-596.
34. Fernandez-Rodriguez E, Quinteiro C, Barreiro J, et al. Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: prevalence, evolution of hormone dysfunction and genetic analysis. Neuroendocrinology. 2011;93:181-188.
35. Rainbow LA, Rees SA, Shaikh MG, et al. Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. Clin Endocrinol. 2005;62:163-168.
36. Dateki S, Fukami M, Uematsu A, et al. Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion. J Clin Endocrinol Metab. 2010;95:4043-4047.
37. Kim SS, Kim Y, Shin YL, Kim GH, Kim TU, Yoo HW. Clinical characteristics and molecular analysis of PIT1, PROP1, LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging. Horm Res. 2003;60:277-283.
38. McLennan K, Jeske Y, Cotterill A, et al. Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates. Clin Endocrinol. 2003;58:785-794.
39. Romero CJ, Pine-Twaddell E, Radovick S. Novel mutations associated with combined pituitary hormone deficiency. J Mol Endocrinol. 2011;46:93-102.
40. Voutetakis A, Argyropoulou M, Sertedaki A, et al. Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J Clin Endocrinol Metab. 2004;89:2200-2206.
41. Voutetakis A, Sertedaki A, Livadas S, et al. Pituitary size fluctuation in long-term MR studies of PROP1 deficient patients: a persistent pathophysiological mechanism? J Endocrinol Invest. 2006;29:462-466.